🇺🇸 FDA

Drug profile · INN

diatrizoate sodium

MD-50

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

diatrizoate sodium (MD-50) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral, rectal. Current US regulatory status: approved.

Key facts

INN diatrizoate sodium
Brand MD-50
Route ORAL, RECTAL
Formulation INJECTABLE

Frequently asked questions

What is diatrizoate sodium?

diatrizoate sodium (MD-50) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral, rectal. Current US regulatory status: approved.

What is the brand name for diatrizoate sodium?

MD-50 is a marketed brand name for diatrizoate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of diatrizoate sodium?

diatrizoate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.